EUVIMEDEUVIMED entdecken
Crossref

Steroid-limited isatuximab-based quadruplet therapy in elderly, transplant-ineligible multiple myeloma: a REST trial commentary

Dennis D. Lee, Faith E. Davies

AME Clinical Trials Review · 2026-04 · 4 · 13-13

DOI: 10.21037/actr-25-81 ↗

Kurz gefasst

Fachartikel in der Zeitschrift AME Clinical Trials Review, 2026-04. Verfasst von Dennis D. Lee und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Lee, D. D., & Davies, F. E. (2026). Steroid-limited isatuximab-based quadruplet therapy in elderly, transplant-ineligible multiple myeloma: a REST trial commentary. AME Clinical Trials Review, 4, 13-13. https://doi.org/10.21037/actr-25-81

Vancouver

Lee DD, Davies FE. Steroid-limited isatuximab-based quadruplet therapy in elderly, transplant-ineligible multiple myeloma: a REST trial commentary. AME Clinical Trials Review. 2026;4:13-13. doi:10.21037/actr-25-81

BibTeX
@article{Lee2026,
  author = {Lee, Dennis D. and Davies, Faith E.},
  title = {Steroid-limited isatuximab-based quadruplet therapy in elderly, transplant-ineligible multiple myeloma: a REST trial commentary},
  journal = {AME Clinical Trials Review},
  year = {2026},
  volume = {4},
  pages = {13--13},
  doi = {10.21037/actr-25-81}
}
Kostenlos starten →